Sjögren's syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody

Hideki Nakamura,Masako Tsukamoto,Kinya Nagata,Yosuke Nagasawa,Kumiko Akiya,Hirotake Inomata,Masahiro Nishihara,Shin-Ya Asatani,Noboru Kitamura,Hisataka Kitano,Jun Shoji,Yu Iwabuchi,Toshiyuki Ishige,Hiroyuki Hao
DOI: https://doi.org/10.1177/03000605241293986
2024-11-08
Journal of International Medical Research
Abstract:Journal of International Medical Research, Volume 52, Issue 11, November 2024. This current case report describes a Japanese woman in her 80s with xerostomia who presented with salivary gland dysfunction. She was positive for isolated anti-Ro52/SS-A antibody as determined by a chemiluminescent enzyme immunoassay and positive on a fluorescence enzyme immunoassay that recognizes both Ro52 and Ro60 antigens. A high serum concentration of anti-Ro52/SS-A antibody was determined by an enzyme-linked immunosorbent assay. A high anti-centromere antibodies (ACA) titre was also observed. Although Raynaud's phenomenon or a high serum immunoglobulin G concentration were not observed, Masson-trichrome staining of the patient's labial salivary glands showed considerable fibrosis. Her serum type I and type II interferon concentrations were normal. The present patient is the first with Sjögren's syndrome (SS) to exhibit isolated anti-Ro52/SS-A antibody and ACA without anti-Ro60/SS-A antibody. This current case report presents her case together with those of four other SS patients who were positive for isolated anti-Ro52/SS-A antibody. The SS literature also includes cases positive for ACA and describes clinical characteristics. The other four SS patients with isolated anti-Ro52/SS-A antibody described here had no ACA; interstitial pneumonia and polyneuropathy were observed in these cases, although there was no consistent tendency regarding types I and II interferon.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?